கிஂக்டந் மூலதனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கிஂக்டந் மூலதனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கிஂக்டந் மூலதனம் Today - Breaking & Trending Today

Tempo lands $200M for digital fitness studio, Benchling scores $200M for pharma research platform and other digital health fundings


Photo by IronHeart/Getty Images
At-home digital fitness studio Tempo has raised $220 million in its recently closed Series C funding round. SoftBank Vision Fund 2 led the round with additional participation from new investor Steadfast Capital Ventures and returning investors DCM, General Catalyst, Norwest Venture Partners, and Bling Capital.
Tempo plans to use the money to continue enhancing its artificial intelligence and 3D sensor tracking technology. The company’s flagship workout device scans users 30 times per second to guide users through the session while correcting their form when necessary.
Coming less than a year after its $60 million raise, Tempo now has nearly $300 million in funding to date. ....

United States , Palo Alto , Carine Carmy , Patrick Fu , Michelle Longmire , Roy Beveridge , Andreessen Horowitz , Elad Gil , Annie Lamont , Softbank Vision Fund , Schroder Co , Blue Venture Fund , Ypsomed Group , Bank Vision Fund , Steadfast Capital Ventures , General Catalyst , Norwest Venture Partners , Capital Global Equities , Altimeter Capital , Byers Capital , Sequoia Capital Global Equities , Suisse Entrepreneur Capital , Endeavour Vision , Tandem Diabetes Care , Federated Hermes Kaufmann Funds , Kingdon Capital ,

A String of Developments in the Diabetes Management Space


CeQur, Medtronic, Roche, and Biocorp made moves in the diabetes market.
CeQur has raised $115 million in an oversubscribed equity financing. The Lucerne, Switzerland-based company has developed CeQur Simplicity, a wearable insulin delivery system.
Credit Suisse Entrepreneur Capital Ltd. and Endeavour Vision led the financing with significant participation from new investors, including Tandem Diabetes Care, Ypsomed Group, Federated Hermes Kaufmann Funds, Kingdon Capital, and GMS Capital, as well as existing investors, Schroder & Co. Bank SA, and VI Partners.
Proceeds from the financing will be used to advance commercial plans for CeQur Simplicity, including market development activities, a phased commercial launch strategy that includes a limited market release in 2021, and the scale-up of high-volume manufacturing. ....

John Sheridan , Eric Dessertenne , Credit Suisse Entrepreneur Capital Ltd , Schroder Co , Ypsomed Group , Cequr Simplicity , Suisse Entrepreneur Capital , Endeavour Vision , Tandem Diabetes Care , Federated Hermes Kaufmann Funds , Kingdon Capital , Qur Simplicity , Roche Diabetes Care France , Roche Diabetes Care , ஜான் ஷெரிடன் , கடன் ஸ்யூயி தொழில்முனைவோர் மூலதனம் லிமிடெட் , ஸ்க்ரோடர் இணை , ஸ்யூயி தொழில்முனைவோர் மூலதனம் , முயற்சி பார்வை , ட்யாஂடம் நீரிழிவு நோய் பராமரிப்பு , கூட்டமைப்பு ஹெர்ம்ஸ் காஃப்மந் நிதி , கிஂக்டந் மூலதனம் , ரோச் நீரிழிவு நோய் பராமரிப்பு பிரான்ஸ் , ரோச் நீரிழிவு நோய் பராமரிப்பு ,